Cost Effectiveness Of Warfarin Dose Genotyping To Be Assessed In Medco/Mayo Clinic Study
This article was originally published in The Pink Sheet Daily
Executive Summary
Study will determine if the cost of testing is justified by the savings created in preventing warfarin-related bleeding events.